Developing a universal influenza vaccine — a vaccine that can provide durable protection for all age groups against multiple influenza strains, including those that might cause a pandemic — is...

Vaccinations have begun in a multi-site Phase 2/2b clinical trial testing an experimental DNA vaccine designed to protect against disease caused by Zika infection. The vaccine was developed by government...

A novel vaccine developed by scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, protected cattle from respiratory syncytial virus...

Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health (NIH), and colleague Catharine I. Paules, M.D. published...

By

NIAID scientists and their Central African and French colleagues have developed a tool to detect high blood levels of the parasitic worm Loa loa, a risk factor for adverse reactions to the broad-spectrum...